↓
 
Home→News→GSK, CureVac team up to develop vaccine against Covid-19 variants

GSK, CureVac team up to develop vaccine against Covid-19 variants

South African Newspapers

Britain’s GlaxoSmithKline and German biotech firm CureVac have teamed up in a 150 million euro ($180 million) deal to develop a Covid-19 vaccine from next year that could target several variants with one shot.

Comments

GSK, CureVac team up to develop vaccine against Covid-19 variants — No Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

HTML tags allowed in your comment: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

↑